Shopping Cart 0
Cart Subtotal
USD 0

Protalix BioTherapeutics Inc (PLX) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Protalix BioTherapeutics Inc (PLX)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Protalix BioTherapeutics Inc (Protalix) is a biopharmaceutical company that develops and commercializes recombinant therapeutic proteins. The company's marketed product, Taliglucerase (taliglucerase alfa) is an enzyme replacement therapy (ERT) for the long-term treatment of adult patients with a confirmed diagnosis of type 1 Gaucher disease. The company also has pipeline product candidates that are intended for the treatment of Fabry disease; cystic fibrosis and gaucher disease. Protalix develops its proprietary pipeline of recombinant therapeutic proteins through its proprietary technology: ProCellEx System. Protalix is headquartered in Carmiel, Israel

Protalix BioTherapeutics Inc Key Recent Developments

Sep 21,2018: Protalix BioTherapeutics Reports Positive Preliminary Data from the BRIDGE Study of pegunigalsidase alfa for the Treatment of Fabry Disease

Aug 13,2018: Protalix Biotherapeutics names David Granot as board director

Aug 09,2018: Protalix BioTherapeutics reports 2018 second quarter results and provides corporate update

May 09,2018: Protalix BioTherapeutics Reports 2018 First Quarter Results and Provides Corporate Update

Mar 06,2018: Protalix BioTherapeutics Reports 2017 Full Year Results and Provides Corporate Update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Protalix BioTherapeutics Inc-Key Facts 5

Protalix BioTherapeutics Inc-Key Employees 6

Protalix BioTherapeutics Inc-Key Employee Biographies 7

Protalix BioTherapeutics Inc-Major Products and Services 8

Protalix BioTherapeutics Inc-History 9

Protalix BioTherapeutics Inc-Company Statement 10

Protalix BioTherapeutics Inc-Locations And Subsidiaries 12

Head Office 12

Other Locations & Subsidiaries 12

Section 2-Company Analysis 13

Company Overview 13

Protalix BioTherapeutics Inc-Business Description 14

R&D Overview 14

Protalix BioTherapeutics Inc-Corporate Strategy 15

Protalix BioTherapeutics Inc-SWOT Analysis 16

SWOT Analysis-Overview 16

Protalix BioTherapeutics Inc-Strengths 16

Protalix BioTherapeutics Inc-Weaknesses 17

Protalix BioTherapeutics Inc-Opportunities 18

Protalix BioTherapeutics Inc-Threats 19

Protalix BioTherapeutics Inc-Key Competitors 20

Section 3-Company Financial Ratios 21

Financial Ratios-Capital Market Ratios 21

Financial Ratios-Annual Ratios 22

Performance Chart 25

Financial Performance 25

Financial Ratios-Interim Ratios 26

Financial Ratios-Ratio Charts 27

Section 4-Company's Lifesciences Financial Deals and Alliances 28

Protalix BioTherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28

Protalix BioTherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29

Protalix BioTherapeutics Inc, Recent Deals Summary 30

Section 5-Company's Recent Developments 31

Aug 09, 2018: Protalix BioTherapeutics reports 2018 second quarter results and provides corporate update 31

May 09, 2018: Protalix BioTherapeutics Reports 2018 First Quarter Results and Provides Corporate Update 32

Mar 06, 2018: Protalix BioTherapeutics Reports 2017 Full Year Results and Provides Corporate Update 33

Nov 08, 2017: Protalix BioTherapeutics Reports 2017 Third Quarter Results and Provides Corporate Update 34

Aug 09, 2017: Protalix BioTherapeutics Reports 2017 Second Quarter Results and Provides Corporate Update 35

May 10, 2017: Protalix BioTherapeutics Reports 2017 First Quarter Results and Provides Corporate Update 37

Mar 16, 2017: Protalix BioTherapeutics Reports 2016 Full Year Results and Provides Corporate Update 38

Jan 09, 2017: Protalix BioTherapeutics Provides Review of 2016 and Strategic Outlook for 2017 39

Section 6-Appendix 40

Methodology 40

Ratio Definitions 40

About GlobalData 44

Contact Us 44

Disclaimer 44


List Of Figure

List of Figures

Protalix BioTherapeutics Inc, Performance Chart (2013-2017) 25

Protalix BioTherapeutics Inc, Ratio Charts 27

Protalix BioTherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28

Protalix BioTherapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 29


List Of Table

List of Tables

Protalix BioTherapeutics Inc, Key Facts 5

Protalix BioTherapeutics Inc, Key Employees 6

Protalix BioTherapeutics Inc, Key Employee Biographies 7

Protalix BioTherapeutics Inc, Major Products and Services 8

Protalix BioTherapeutics Inc, History 9

Protalix BioTherapeutics Inc, Subsidiaries 12

Protalix BioTherapeutics Inc, Key Competitors 20

Protalix BioTherapeutics Inc, Ratios based on current share price 21

Protalix BioTherapeutics Inc, Annual Ratios 22

Protalix BioTherapeutics Inc, Annual Ratios (Cont...1) 23

Protalix BioTherapeutics Inc, Annual Ratios (Cont...2) 24

Protalix BioTherapeutics Inc, Interim Ratios 26

Protalix BioTherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28

Protalix BioTherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29

Protalix BioTherapeutics Inc, Recent Deals Summary 30

Currency Codes 40

Capital Market Ratios 40

Equity Ratios 41

Profitability Ratios 41

Cost Ratios 42

Liquidity Ratios 42

Leverage Ratios 43

Efficiency Ratios 43

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Protalix BioTherapeutics Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Shire LLC

Genzyme Corp

Genentech Inc

Can-Fite BioPharma Ltd

BiondVax Pharmaceuticals Ltd

Amicus Therapeutics Inc